Australian Super Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History

Australian Super Pty LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$700.03 - $830.35 $82 Million - $97.3 Million	-117,164 Reduced 99.28%	855 $614,000
Q1 2023 Apr 21, 2023	BUY	$680.49 - $826.97 $969,017 - $1.18 Million	1,424 Added 1.22%	118,019 $97 Million
Q4 2022 Feb 01, 2023	SELL	$705.89 - $766.39 $10.1 Million - $11 Million	-14,374 Reduced 10.98%	116,595 $84.1 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $38.3 Million - $48.3 Million	66,692 Added 103.76%	130,969 $90.2 Million
Q2 2022 Jul 13, 2022	BUY	$548.35 - $738.84 $35.2 Million - $47.5 Million	64,277 New	64,277 $38 Million
Q4 2021 Jan 24, 2022	SELL	$543.48 - $670.97 $41.2 Million - $50.8 Million	-75,725 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $6 Million - $7.12 Million	-10,450 Reduced 12.13%	75,725 $45.8 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $7.42 Million - $8.76 Million	15,684 Added 22.25%	86,175 $48.1 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $24.2 Million - $29.7 Million	54,096 Added 329.95%	70,491 $33.4 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $7.84 Million - $9.97 Million	16,395 New	16,395 $7.92 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $3.28 Million - $3.96 Million	-6,015 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.97 Million - $3.87 Million	6,015 New	6,015 $3.75 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Australian Super Pty LTD with notifications on news.